Global Hepatitis A Vaccine Market Status and Outlook 2018-2025

August 2018 | 140 pages | ID: G6810540BC8EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• GlaxoSmithKline
• Merck Sharp & Dohme Corp
• SANOFI PASTEUR S.A
• Norvatis
• Crucell Switzerland AG(Berna+Crucell)
• China Academy of Medical Sciences
• Changchun Institute of Biological Products
• Zhejiang Pukang
• ChangSheng
• Sinovac
• Shanghai Zerun Biotechnology

Market by Type

• Liver Inactivated Vaccine
• Live Attenuated Vaccine

Market by Application

• Hospitals
• Other Medical Institutions

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Hepatitis A Vaccine Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Liver Inactivated Vaccine
  3.1.2 Live Attenuated Vaccine
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospitals
  4.1.2 Other Medical Institutions
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Liver Inactivated Vaccine Production by Region
    6.1.1.2 Live Attenuated Vaccine Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospitals Production by Region
    6.1.2.2 Other Medical Institutions Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Liver Inactivated Vaccine Demand by Region
    6.2.1.2 Live Attenuated Vaccine Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospitals Demand by Region
    6.2.2.2 Other Medical Institutions Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 GlaxoSmithKline
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Merck Sharp & Dohme Corp
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 SANOFI PASTEUR S.A
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Norvatis
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Crucell Switzerland AG(Berna+Crucell)
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 China Academy of Medical Sciences
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Changchun Institute of Biological Products
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Zhejiang Pukang
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 ChangSheng
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Sinovac
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Shanghai Zerun Biotechnology

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Hepatitis A Vaccine Industry Dynamics & Regulations List
Table Global Hepatitis A Vaccine Sales Revenue, Cost and Margin, 2015-2018E
Table Global Hepatitis A Vaccine Market Status by Type 2015-2018E, in USD Million
Table Global Hepatitis A Vaccine Market Status by Application 2015-2018E, in USD Million
Table Global Hepatitis A Vaccine Market Status by Application 2015-2018E, in Volume
Table Global Hepatitis A Vaccine Market by Region 2015-2018E, in USD Million
Table Global Hepatitis A Vaccine Market Share by Region in 2018, in USD Million
Table Global Hepatitis A Vaccine Market by Region 2015-2018E, in Volume
Table Global Hepatitis A Vaccine Market Share by Region in 2018, in Volume
Table Liver Inactivated Vaccine Production Value by Region 2015-2018E, in USD Million
Table Liver Inactivated Vaccine Production Volume by Region 2015-2018E, in Volume
Table Live Attenuated Vaccine Production Value by Region 2015-2018E, in USD Million
Table Live Attenuated Vaccine Production Volume by Region 2015-2018E, in Volume
Table Hospitals Production Value by Region 2015-2018E, in USD Million
Table Hospitals Production Volume by Region 2015-2018E, in Volume
Table Other Medical Institutions Production Value by Region 2015-2018E, in USD Million
Table Other Medical Institutions Production Volume by Region 2015-2018E, in Volume
Table Liver Inactivated Vaccine Market Size by Region 2015-2018E, in USD Million
Table Liver Inactivated Vaccine Market Size by Region 2015-2018E, in Volume
Table Live Attenuated Vaccine Market Size by Region 2015-2018E, in USD Million
Table Live Attenuated Vaccine Market Size by Region 2015-2018E, in Volume
Table Hospitals Market Size by Region 2015-2018E, in USD Million
Table Hospitals Market Size by Region 2015-2018E, in Volume
Table Other Medical Institutions Market Size by Region 2015-2018E, in USD Million
Table Other Medical Institutions Market Size by Region 2015-2018E, in Volume
Table GlobalHepatitis A Vaccine Forecast by Type 2019F-2025F, in USD Million
Table Hepatitis A Vaccine Forecast by Type 2019F-2025F, in Volume
Table Hepatitis A Vaccine Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Hepatitis A Vaccine Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Hepatitis A Vaccine Market Forecast by Region 2019F-2025F, in USD Million
Table Hepatitis A Vaccine Market Forecast by Region 2019F-2025F, in Volume
Table GlaxoSmithKline Information
Table Hepatitis A Vaccine Sales, Cost, Margin of GlaxoSmithKline
Table Merck Sharp & Dohme Corp Information
Table Hepatitis A Vaccine Sales, Cost, Margin of Merck Sharp & Dohme Corp
Table SANOFI PASTEUR S.A Information
Table Hepatitis A Vaccine Sales, Cost, Margin of SANOFI PASTEUR S.A
Table Norvatis Information
Table Hepatitis A Vaccine Sales, Cost, Margin of Norvatis
Table Crucell Switzerland AG(Berna+Crucell) Information
Table Hepatitis A Vaccine Sales, Cost, Margin of Crucell Switzerland AG(Berna+Crucell)
Table China Academy of Medical Sciences Information
Table Hepatitis A Vaccine Sales, Cost, Margin of China Academy of Medical Sciences
Table Changchun Institute of Biological Products Information
Table Hepatitis A Vaccine Sales, Cost, Margin of Changchun Institute of Biological Products
Table Zhejiang Pukang Information
Table Hepatitis A Vaccine Sales, Cost, Margin of Zhejiang Pukang
Table ChangSheng Information
Table Hepatitis A Vaccine Sales, Cost, Margin of ChangSheng
Table Sinovac Information
Table Hepatitis A Vaccine Sales, Cost, Margin of Sinovac
Table Shanghai Zerun Biotechnology Information
Table Hepatitis A Vaccine Sales, Cost, Margin of Shanghai Zerun Biotechnology
Table Global Hepatitis A Vaccine Sales Revenue by Company 2015-2017, in USD Million
Table Global Hepatitis A Vaccine Sales Volume by Company 2015-2017, in Volume
Table Global Hepatitis A Vaccine Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Hepatitis A Vaccine Picture
Figure Hepatitis A Vaccine Industry Chain Diagram
Figure Global Hepatitis A Vaccine Sales Revenue 2015-2018E, in USD Million
Figure Global Hepatitis A Vaccine Sales Volume 2015-2018E, in Volume
Figure Global Hepatitis A Vaccine Market Status by Type 2015-2018E, in Volume
Figure North America Hepatitis A Vaccine Market Size and Growth 2015-2018E, in USD Million
Figure North America Hepatitis A Vaccine Market Size and Growth 2015-2018E, in Volume
Figure Europe Hepatitis A Vaccine Market Size and Growth 2015-2018E, in USD Million
Figure Europe Hepatitis A Vaccine Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Hepatitis A Vaccine Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Hepatitis A Vaccine Market Size and Growth 2015-2018E, in Volume
Figure South America Hepatitis A Vaccine Market Size and Growth 2015-2018E, in USD Million
Figure South America Hepatitis A Vaccine Market Size and Growth 2015-2018E, in Volume
Figure Middle East Hepatitis A Vaccine Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Hepatitis A Vaccine Market Size and Growth 2015-2018E, in Volume
Figure Africa Hepatitis A Vaccine Market Size and Growth 2015-2018E, in USD Million
Figure Africa Hepatitis A Vaccine Market Size and Growth 2015-2018E, in Volume
Figure Global Hepatitis A Vaccine Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Hepatitis A Vaccine Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Hepatitis A Vaccine Sales Price Forecast 2019F-2025F
Figure Global Hepatitis A Vaccine Gross Margin Forecast 2019F-2025F
Figure Global Hepatitis A Vaccine Sales Revenue by Company in 2018, in USD Million
Figure Global Hepatitis A Vaccine Price by Company in 2018
Figure Global Hepatitis A Vaccine Gross Margin by Company in 2018